Weston vehicle deal to buy Boots lifts healthcare shares

Canadian Weston-family-controlled investment vehicle agreed to buy U.K. pharmacy chain Boots for $8.9 billion including debt, supporting a rise in healthcare stocks amid defensive-sector rotation. Other items cited include Merck’s Keytruda sales ban in eight European markets and Becton Dickinson’s push to expand U.S. manufacturing.